iSpecimen Inc has a consensus price target of $12.13, established from looking at the 3 latest analyst ratings. The last 3 analyst ratings were released from EF Hutton, Craig-Hallum, and EF Hutton on September 23, 2022, January 4, 2022, and November 22, 2021. With an average price target of $12.08 between EF Hutton, Craig-Hallum, and EF Hutton, there's an implied 4893.11% upside for iSpecimen Inc from these 3 analyst ratings.
1calculated from analyst ratings published within the last 3 years
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|
09/23/2022 | ISPC | Buy Now | iSpecimen | $0.24 | 1656.2% | EF Hutton | Constantine Davides | $5.5 → $4.25 | Maintains | Buy | Get Alert |
01/04/2022 | ISPC | Buy Now | iSpecimen | $0.24 | 8164.46% | Craig-Hallum | Matt Hewitt | → $20 | Initiates | → Buy | Get Alert |
11/22/2021 | ISPC | Buy Now | iSpecimen | $0.24 | 4858.68% | EF Hutton | Constantine Davides | — | Maintains | Buy | Get Alert |
The latest price target for iSpecimen (NASDAQ: ISPC) was reported by EF Hutton on September 23, 2022. The analyst firm set a price target for $4.25 expecting ISPC to rise to within 12 months (a possible 1670.83% upside). 0 analyst firms have reported ratings in the last year.
The latest analyst rating for iSpecimen (NASDAQ: ISPC) was provided by EF Hutton, and iSpecimen maintained their buy rating.
There is no last upgrade for iSpecimen.
There is no last downgrade for iSpecimen.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of iSpecimen, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for iSpecimen was filed on September 23, 2022 so you should expect the next rating to be made available sometime around September 23, 2023.
While ratings are subjective and will change, the latest iSpecimen (ISPC) rating was a maintained with a price target of $5.50 to $4.25. The current price iSpecimen (ISPC) is trading at is $0.24, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.